Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Overall survival and PD-L1 expression in metastasized malignant melanoma
Jules Gadiot
, Anna I. Hooijkaas
, Andrew D.M. Kaiser
,
Harm Van Tinteren
, Hester Van Boven
, Christian Blank
Research output
:
Contribution to journal
›
Article
›
peer-review
214
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Overall survival and PD-L1 expression in metastasized malignant melanoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Overall Survival
100%
Metastasizing
100%
Malignant Melanoma
100%
PD-L1 Expression
100%
Transforming Growth Factor-β
33%
Programmed Death-ligand 1 (PD-L1)
33%
Melanoma Patients
33%
Primary Melanoma
33%
Immunologic Factors
33%
Tumor
16%
Netherlands
16%
Patient Cohort
16%
Metastatic Disease
16%
Prognostic Relevance
16%
CD8+ T Cells
16%
Distant Metastasis
16%
Regulatory T Cells
16%
Patient Survival
16%
Disease Progression
16%
Prognostic Marker
16%
Negative Association
16%
Immune System
16%
Longitudinal Analysis
16%
Systemic Therapy
16%
Inhibitory Receptors
16%
CD4 T Cells
16%
Lymph Node
16%
MHC Class II
16%
Paraffin Embedding
16%
Conflicting Results
16%
Sentinel Node Procedure
16%
Breslow Thickness
16%
Impact on Patients
16%
Stage III-IV
16%
Melanoma Cells
16%
Nevus
16%
T Cell Infiltration
16%
B7-H1
16%
Antibody Verification
16%
Tumor Immune Escape
16%
In-transit
16%
Cancer Institute
16%
Medicine and Dentistry
Overall Survival
100%
Programmed Death-Ligand 1
100%
Melanoma
100%
Malignant Neoplasm
25%
Neoplasm
25%
Metastatic Carcinoma
25%
Transforming Growth Factor Beta
25%
T Cell
12%
Systemic Therapy
12%
Cytotoxic T-Cell
12%
Upregulation
12%
Cellular Infiltration
12%
Programmed Cell Death
12%
Receptor
12%
Regulatory T Cell
12%
T-Helper Cell
12%
Clinical Study
12%
Disease Exacerbation
12%
Immune System
12%
Secretion (Process)
12%
Lymph Node
12%
Sentinel Node
12%
Melanoma Cell
12%
Immunity
12%
Nevus
12%
Immunology and Microbiology
Overall Survival
100%
Programmed Death-Ligand 1
100%
Transforming Growth Factor Beta
25%
T Cell
12%
Immune Escape
12%
Cell Death
12%
Cell Infiltration
12%
Secretion (Process)
12%
Regulatory T Cell
12%
Lymph Node
12%
Upregulation
12%
Immune System
12%
Melanoma Cell
12%
CD4
12%
CD8
12%
Immunology
12%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
PD-L1
100%
Transforming Growth Factor Beta
25%
Immunity
25%
T Cell
12%
CD8
12%
Cell Death
12%
Upregulation
12%
Secretion (Process)
12%
Regulatory T Cell
12%
Clinical Study
12%
CD4
12%
Cell Infiltration
12%